Advertisement
MCP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/mcp.M700198-MCP200 on November 5, 2007.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow A correction has been published
Right arrow All Versions of this Article:
M700198-MCP200v1
M700198-MCP200v2
7/2/378    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Glossary
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barceló-Batllori, S.
Right arrow Articles by Gomis, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barceló-Batllori, S.
Right arrow Articles by Gomis, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular & Cellular Proteomics 7:378-393, 2008.
© 2008 by The American Society for Biochemistry and Molecular Biology, Inc.


Research

Integration of DIGE and Bioinformatics Analyses Reveals a Role of the Antiobesity Agent Tungstate in Redox and Energy Homeostasis Pathways in Brown Adipose Tissue *,S

Sílvia Barceló-Batllori{ddagger},§, Susana G. Kalko, Yaiza Esteban{ddagger}, Sílvia Moreno{ddagger}, María C. Carmona{ddagger} and Ramon Gomis{ddagger},||

From the {ddagger} Laboratory of Experimental Diabetes and Obesity, Endocrinology and Diabetes Unit, and Bioinformatics Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, E-08036 Barcelona, Catalonia, Spain

Our previous results demonstrated that tungstate decreased weight gain and adiposity in obese rats through increased thermogenesis and lipid oxidation, suggesting that brown adipose tissue was one of the targets of its antiobesity effect. To identify potential targets of tungstate, we used DIGE to compare brown adipose tissue protein extracts from the following experimental groups: untreated lean, tungstate-treated lean, untreated obese, and tungstate-treated obese rats. To distinguish direct targets of tungstate action from those that are secondary to body weight loss, we also included in the analysis an additional group consisting of obese rats that lose weight by caloric restriction. Hierarchical clustering of analysis of variance and t test contrasts clearly separated the different experimental groups. DIGE analysis identified 20 proteins as tungstate obesity direct targets involved in Krebs cycle, glycolysis, lipolysis and fatty acid oxidation, electron transport, and redox. Protein oxidation was decreased by tungstate treatment, confirming a role in redox processes; however, palmitate oxidation, as a measure of fatty acid β-oxidation, was not altered by tungstate, thus questioning its putative function in fatty acid oxidation. Protein network analyses using Ingenuity Pathways Analysis highlighted peroxisome proliferator-activated receptor {gamma} coactivator 1{alpha} (PGC-1{alpha}) as a potential target. We confirmed by real time PCR that indeed tungstate up-regulates PGC-1{alpha}, and its major target, uncoupling protein 1, was also increased as shown by Western blot. These results illustrate the utility of proteomics and bioinformatics approaches to identify targets of obesity therapies and suggest that in brown adipose tissue tungstate modulates redox processes and increases energy dissipation through uncoupling and PGC-1{alpha} up-regulation, thus contributing to its overall antiobesity effect.


§ To whom correspondence may be addressed: Laboratory of Experimental of Diabetes and Obesity, IDIBAPS, C/ Villarroel 170, E-08036 Barcelona, Spain. Tel.: 34-93-2275400, ext. 2910; Fax: 34-93-4516638; E-mail: sbarcelo{at}clinic.ub.es

|| To whom correspondence may be addressed: Endocrinology and Diabetes Unit, Hospital Clinic, C/ Villarroel 170, E-08036 Barcelona, Spain. Tel.: 34-93-2279846; Fax: 34-93-4516638; E-mail: rgomis{at}clinic.ub.es


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
I. Canals, M. C. Carmona, M. Amigo, A. Barbera, A. Bortolozzi, F. Artigas, and R. Gomis
A Functional Leptin System Is Essential for Sodium Tungstate Antiobesity Action
Endocrinology, February 1, 2009; 150(2): 642 - 650.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement